Validity and reliability of the FACT-G scale for use in the older person with cancer

被引:114
作者
Overcash, J
Extermann, M
Parr, J
Perry, J
Balducci, L
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Senior Adult Oncol Program, Tampa, FL 33612 USA
[2] Univ S Florida, Florida Mental Hlth Inst, Dept Aging & Mental Hlth, Tampa, FL 33612 USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2001年 / 24卷 / 06期
关键词
quality of life; fact-G; SF-36; cancer; elderly patients;
D O I
10.1097/00000421-200112000-00013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This project was designed to evaluate the Functional Assessment of Cancer Therapy General Scale (FACT-G) for use in the older patient with cancer. Subjects were administered the MOS Short Form Health Survey (SF-36) and the FACT-G scale. Subscale and total scores were compared using the Pearson product correlation test. FACT-G total and subscores were compared with the mixed aged cancer patient normative group of Cella et al. (1993). Good correlations were found between total and subscores of the SF-36 and the FACT-G in all areas except vitality. The mean total FACT-G score was 82.2 +/- 16.2 SD for the patients with cancer, and 92.3 +/- 11.8 SD for community-dwelling elderly (CDE). The FACT-G was able to discriminate between patients that received cancer care and CDE (p < 0.002). Subjects who scored higher on the FACT-G were found to have higher Eastern Cooperative Oncology Group Performance Status (PS), Subjects with a PS of 0 had a mean total FACT-G score of 87.9 +/- 14.4 SD. Subjects with a PS of 3 had a mean score of 59.0 +/- 212 SD, The FACT-G is a valid and reliable instrument for use in the older patient with cancer. The FACT-G is not an age-biased instrument.
引用
收藏
页码:591 / 596
页数:6
相关论文
共 32 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
BALDUCCI L, 1994, DRUGS AGING, V4, P314
[3]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[4]  
CHARLSON M, 1993, J CHRON DIS, V40, P737
[5]   PROGNOSTIC VALUE OF QUALITY-OF-LIFE SCORES DURING CHEMOTHERAPY FOR ADVANCED BREAST-CANCER [J].
COATES, A ;
GEBSKI, V ;
SIGNORINI, D ;
MURRAY, P ;
MCNEIL, D ;
BYRNE, M ;
FORBES, JF .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) :1833-1838
[6]  
COSCARELLISHAG CA, 1990, ONCOLOGY, V4, P135
[7]  
Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
[8]   Quality of life assessment in daily clinical oncology practice: A feasibility study [J].
Detmar, SB ;
Aaronson, NK .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (08) :1181-1186
[9]   Comorbidity and functional status are independent in older cancer patients [J].
Extermann, M ;
Overcash, J ;
Lyman, GH ;
Parr, J ;
Balducci, L .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1582-1587
[10]   LONG-TERM SURVIVORS IN METASTATIC NON SMALL-CELL LUNG-CANCER - AN EASTERN COOPERATIVE ONCOLOGY GROUP-STUDY [J].
FINKELSTEIN, DM ;
ETTINGER, DS ;
RUCKDESCHEL, JC .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) :702-709